human | Q5 |
P268 | Bibliothèque nationale de France ID | 13533256z |
P227 | GND ID | 138513597 |
P2671 | Google Knowledge Graph ID | /g/11hz8ljttr |
P269 | IdRef ID | 050508318 |
P213 | ISNI | 0000000081607250 |
P244 | Library of Congress authority ID | n82225237 |
P8189 | National Library of Israel J9U ID | 987007325133805171 |
P691 | NL CR AUT ID | nlk20040157535 |
P496 | ORCID iD | 0000-0002-7945-9863 |
P7293 | PLWABN ID | 9810587804405606 |
P4012 | Semantic Scholar author ID | 144406676 |
P214 | VIAF ID | 84864143 |
P735 | given name | Wilbert | Q4019747 |
Wilbert | Q4019747 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q49953623 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clini |
Q50043295 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clini |
Q57796491 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinic |
Q89238011 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association |
Q57796488 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association T |
Q91466330 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association |
Q89290518 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association |
Q98474117 | A Case of Spontaneous Pneumothorax 21 Days After Diagnosis of Coronavirus Disease 2019 (COVID-19) Pneumonia |
Q98783396 | A Review of Diagnosis, Etiology, Assessment and Management of Patients with Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease |
Q82200209 | A cardiologist's experience undergoing quadruple coronary artery bypass surgery |
Q84232367 | A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID) |
Q81730047 | A focus on when and when not to use antiarrhythmic drugs in treating ventricular arrhythmias and indications for the use of automatic implantable cardioverter-defibrillators |
Q37305347 | A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study |
Q89868013 | A meta-analysis of 1-year outcomes of transcatheter versus surgical aortic valve replacement in low-risk patients with severe aortic stenosis |
Q35674273 | A new baseline scoring system may help to predict response to cardiac resynchronization therapy |
Q92071473 | A nomogram for the prediction of cerebrovascular disease among patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma |
Q37768209 | A novel two-dimensional echocardiographic finding in cardiac amyloidosis |
Q83319558 | A patient selection score for cardiac resynchronization therapy |
Q84962143 | A planar QRS-T angle >90 degrees is associated with multivessel coronary artery disease in patients undergoing coronary angiography |
Q37171176 | A propensity-matched study of elevated jugular venous pressure and outcomes in chronic heart failure |
Q37199701 | A propensity-matched study of outcomes of chronic heart failure (HF) in younger and older adults |
Q34019034 | A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults. |
Q37199704 | A propensity-matched study of the association of physical function and outcomes in geriatric heart failure |
Q87437958 | A rare concurrence: nonischemic cardiomyopathy and multiple myeloma without amyloidosis |
Q37360218 | A rare presentation of acute heart failure secondary to aggressive uterine leiomyosarcoma metastatic to the myocardium initially diagnosed as hypertrophic obstructive cardiomyopathy |
Q33163423 | A review of the pathophysiology, diagnosis, and treatment of aortic valve stenosis in elderly patients |
Q82753439 | ACC/AHA guideline update: treatment of heart failure with reduced left ventricular ejection fraction |
Q34180417 | ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents |
Q54128081 | ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, Am |
Q34180723 | ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, Am |
Q41387053 | Ablation of long-standing persistent atrial fibrillation |
Q55169380 | Abnormal chest X-ray leading to diagnosis of partial anomalous pulmonary venous connection. |
Q100456528 | Aconite Poisoning-Induced Ventricular Arrhythmia |
Q46073178 | Acute and chronic management of atrial fibrillation in patients with late-stage CKD. |
Q91403054 | Acute myocardial infarction in the young - National Trend Analysis with gender-based difference in outcomes |
Q98384350 | Acute myocardial infarction in the young with diabetes mellitus- national inpatient sample study with sex-based difference in outcomes |
Q46954879 | Adequacy of control of hypertension in an academic nursing home |
Q39158670 | Advances in chemical pharmacotherapy for managing acute decompensated heart failure |
Q90608277 | Advances in our understanding of the influence of gender on patient outcomes with peripheral arterial disease co-occurring with diabetes |
Q93192983 | Advances in the Pharmacogenomics of Antiplatelet Therapy |
Q80511382 | Age- and sex-related differences in the tissue Doppler imaging parameters of left ventricular diastolic dysfunction |
Q30238535 | Ambulatory pulmonary artery pressure monitoring in advanced heart failure patients |
Q28188128 | Anomalous origin of the left main coronary artery from the right sinus of Valsalva with an intramural course identified by transesophageal echocardiography in a 14 year old with acute myocardial infarction |
Q38398181 | Antiarrhythmic properties of ranolazine: A review of the current evidence. |
Q103722120 | Anticoagulation in Pulmonary Arterial Hypertension: Do We Know the Answer? |
Q89331052 | Antihypertensive drug therapy |
Q38079917 | Antiplatelet drug use in patients with non-ST-segment elevation acute coronary syndromes |
Q28213205 | Antiplatelet therapy in peripheral arterial disease |
Q28222076 | Antiplatelet therapy in the treatment of atherothrombotic disease: considering the evidence |
Q33155702 | Aortic stenosis |
Q79901879 | Approach to AF in older adults on target |
Q92507851 | Approaches for the Management of Resistant Hypertension in 2020 |
Q79344481 | Appropriate use of digoxin in treating older nursing home patients with heart failure |
Q51796110 | Are the extent, location, and score of segmental wall motion abnormalities related to cardiac resynchronization therapy response? |
Q39106784 | Are two drugs better than one? A review of combination therapies for hypertension |
Q89593539 | Arrhythmogenic Right Ventricular Cardiomyopathy Diagnosis |
Q44988480 | Article by Nylen and colleagues. Prognostic effect of exercise capacity on mortality in older adults with diabetes mellitus |
Q90719873 | Aspirin for Primary Prevention of Coronary Artery Disease |
Q34389842 | Assessment of neovascularization within carotid plaques in patients with ischemic stroke |
Q38792007 | Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement |
Q43413268 | Association Between Opioid Abuse/Dependence and Outcomes in Hospitalized Heart Failure Patients |
Q90731401 | Association between depression and readmission of heart failure: A national representative database study |
Q92069544 | Association between direct-acting oral anticoagulants vs. warfarin with the risk of osteoporosis in patients with non-valvular atrial fibrillation |
Q73370494 | Association between plasma homocysteine and extracranial carotid arterial disease in older persons |
Q74554121 | Association between plasma homocysteine and peripheral arterial disease in older persons |
Q35981556 | Association between smoking and outcomes in older adults with atrial fibrillation |
Q39612450 | Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure |
Q46112387 | Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement |
Q40265021 | Association of Obesity With In-Hospital Mortality of Cardiogenic Shock Complicating Acute Myocardial Infarction |
Q71827638 | Association of Silent Myocardial Ischemia with New Atherothrombotic Brain Infarction in Older Patients With Extracranial Internal or Common Carotid Arterial Disease with and without Previous Atherothrombotic Brain Infarction |
Q97073578 | Association of Smokeless Tobacco use with the use of other Illicit Drugs in the United States |
Q53641962 | Association of Transesophageal Echocardiographic Findings With the Site of Arterial Occlusion in Patients With Thromboembolic Stroke |
Q42879743 | Association of Warfarin Use With CHADS2 Score in 441 Patients With Nonvalvular Atrial Fibrillation and No Contraindications to Warfarin |
Q44607703 | Association of abnormal serum lipids in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vasc |
Q81563014 | Association of ankle-brachial index with severity of angiographic coronary artery disease in patients with peripheral arterial disease and coronary artery disease |
Q37100532 | Association of chest pain versus dyspnea as presenting symptom for coronary angiography with demographics, coronary anatomy, and 2-year mortality |
Q36142053 | Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention |
Q53191500 | Association of coronary artery calcium with severity of myocardial ischemia in left anterior descending, left circumflex, and right coronary artery territories. |
Q73935867 | Association of coronary risk factors with progression of valvular aortic stenosis in older persons |
Q33163769 | Association of corrected QT interval with long-term mortality in patients with syncope. |
Q80306540 | Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus |
Q77430085 | Association of electrocardiographic left ventricular hypertrophy with the incidence of new congestive heart failure |
Q77423866 | Association of extracranial carotid arterial disease and chronic atrial fibrillation with the incidence of new thromboembolic stroke in 1,846 older persons |
Q82966653 | Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellitus |
Q52019430 | Association of interatrial block with development of atrial fibrillation. |
Q78194822 | Association of left ventricular hypertrophy and chronic atrial fibrillation with the incidence of new thromboembolic stroke in 2,384 older persons |
Q81319882 | Association of lung volumes with nocturnal oxygen saturation in obese persons: a possible role for therapeutic continuous positive airway pressure |
Q73200691 | Association of mitral annular calcium and of aortic cuspal calcium with coronary artery disease in older patients |
Q73189795 | Association of mitral annular calcium with prior thromboembolic stroke in older White, African-American, and Hispanic men and women |
Q74264779 | Association of mitral annular calcium with symptomatic peripheral arterial disease in older persons |
Q68816037 | Association of mitral anular calcium with new thromboembolic stroke and cardiac events at 39-month follow-up in elderly patients |
Q58588579 | Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis |
Q42359040 | Association of obesity with hypertension |
Q44699006 | Association of plasma homocysteine in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascul |
Q81215752 | Association of reduced carbon monoxide diffusing capacity with moderate or severe left ventricular diastolic dysfunction in obese persons |
Q81563010 | Association of right ventricular dilatation with bilateral pulmonary embolism, pulmonary embolism in a main pulmonary artery and lobar, segmental and subsegmental pulmonary embolism in 190 patients with acute pulmonary embolism |
Q81420382 | Association of right ventricular dysfunction with in-hospital mortality in patients with acute pulmonary embolism and reduction in mortality in patients with right ventricular dysfunction by pulmonary embolectomy |
Q34088554 | Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication |
Q77156517 | Association of valvular aortic stenosis with symptomatic peripheral arterial disease in older persons |
Q34162996 | Association of warfarin use with valvular and vascular calcification: a review. |
Q88516795 | Atherosclerotic renal artery stenosis |
Q36373695 | Atherosclerotic vascular disease may be associated with osteoporosis or osteopenia in postmenopausal women: a preliminary study |
Q33168630 | Atrial Fibrillation: The New Epidemic of the Ageing World |
Q28192861 | Atrial fibrillation |
Q42398729 | Autofluorescence bronchoscopy for lung cancer screening: a time to reflect |
Q38043280 | Azilsartan, aliskiren, and combination antihypertensives utilizing renin-angiotensin-aldosterone system antagonists |
Q86549167 | Back from the brink: catastrophic antiphospholipid syndrome |
Q90983609 | Benefit-risk review of different drug classes used in chronic heart failure |
Q53115461 | Benefits and Harms of Sacubitril in Adults With Heart Failure and Reduced Left Ventricular Ejection Fraction. |
Q41632368 | Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure. |
Q40829158 | Blood Pressure Goals and Targets in the Elderly |
Q36374410 | Blood pressure j-curve: current concepts |
Q47647527 | Blood pressure target goals from guidelines of 2002-2014. |
Q64977297 | Blood pressure targets for hypertension in patients with type 2 diabetes. |
Q48661570 | Brain natriuretic peptide in heart failure |
Q40549998 | Brugada electrocardiographic pattern in carbon monoxide poisoning |
Q73414397 | C-reactive protein. Should it be considered a coronary risk factor? |
Q51533961 | CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction. |
Q37203236 | Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction |
Q41985416 | Can echocardiographically estimated pulmonary arterial elastance be a non-invasive predictor of pulmonary vascular resistance? |
Q61808336 | Can the echocardiographic LV mass equation reliably demonstrate stable LV mass following acute change in LV load? |
Q43548399 | Carbon monoxide and ventricular fibrillation threshold in dogs with acute myocardial injury |
Q83399533 | Carcinoid heart disease |
Q38735433 | Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions |
Q37654514 | Cardiac amyloidosis: approaches to diagnosis and management |
Q87246935 | Cardiac involvement in hemochromatosis |
Q37587493 | Cardiac papillary fibroelastoma: The need for a timely diagnosis |
Q84956729 | Cardiac resynchronization therapy in patients with intrinsic and right ventricular pacing-induced left bundle branch block pattern |
Q30471147 | Cardiac sarcoidosis: a comprehensive review |
Q91944979 | Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes |
Q93105299 | Cardiotoxicity of Cancer Therapies |
Q57064983 | Cardiotoxicity of cancer chemotherapy in clinical practice |
Q41704131 | Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment |
Q33163812 | Cardiovascular Abnormalities in Carbon Monoxide Poisoning |
Q92201895 | Cardiovascular Outcomes With the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials |
Q91858488 | Cardiovascular Safety and Benefits of Non-Insulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus - Part 1 |
Q91756699 | Cardiovascular Safety and Benefits of Non-Insulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus - Part 2 |
Q90314146 | Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week |
Q48022106 | Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus |
Q41242150 | Cardiovascular benefits of the newer medications for treating type 2 diabetes mellitus |
Q80492402 | Cardiovascular drug therapy in the elderly |
Q37803337 | Cardiovascular drug therapy in the elderly: benefits and challenges |
Q84589076 | Cardiovascular drugs in pregnancy |
Q33389153 | Cardiovascular manifestations in patients with thrombotic thrombocytopenic purpura: a single-center experience |
Q48451314 | Cardiovascular manifestations seen in obstructive sleep apnea |
Q28194120 | Cardiovascular medications taken by patients aged >or=70 years hospitalized for acute coronary syndromes before hospitalization and at hospital discharge |
Q92624513 | Catecholaminergic Polymorphic Ventricular Tachycardia |
Q38228656 | Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States |
Q53660655 | Cerebral hyperperfusion after angioplasty and stenting of a totally occluded left subclavian artery: a case report. |
Q44120547 | Cerebrovascular diseases as primary hospital discharge diagnoses: national trend (1970-2000) among older adults |
Q104261459 | Challenges of Shared Decision Making in Older Patients with COVID-19 |
Q35225793 | Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST) |
Q48550683 | Cholesterol and heart disease in older adults: a conversation with Dr Wilbert S. Aronow. Interview by Dr Ali Ahmed |
Q38612763 | Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Diagnosis, and Management |
Q79322767 | Circadian variation of death from congestive heart failure after prior myocardial infarction in patients >60 years of age |
Q70776623 | Circadian variation of primary cardiac arrest or sudden cardiac death in patients aged 62 to 100 years (mean 82) |
Q72759966 | Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias |
Q44463722 | Circumflex coronary artery occlusion after blunt chest trauma |
Q83284052 | Clinical causes of death of 2372 older persons in a nursing home during 15-year follow-up |
Q28217680 | Clinical characteristics, risk factors, and medical treatment of 561 patients with peripheral arterial disease followed in an academic vascular surgery clinic |
Q36958272 | Clinical factors associated with early readmission among acutely decompensated heart failure patients |
Q81812899 | Clinical geriatrics |
Q74812198 | Clinical judgment |
Q37007817 | Clinical update on the diagnosis and treatment of bacterial endocarditis |
Q99630379 | Closure of patent foramen ovale for secondary prevention of cryptogenic stroke: current perspectives |
Q58579864 | Clozapine-Associated Myocarditis: Is It Time to Start Monitoring? |
Q46045909 | Combination use of a TandemHeart with an extracorporeal oxygenator in the treatment of five patients with refractory cardiogenic shock after acute myocardial infarction |
Q73677733 | Commentary on "Embracing complexity: A consideration of hypertension in the very old" |
Q34974314 | Commentary on recent guidelines for treating hypertension |
Q57073515 | Comparative Clinical Outcomes of Edoxaban in Adults With Nonvalvular Atrial Fibrillation |
Q93265334 | Comparative Effectiveness and Safety of Rivaroxaban in Adults With Nonvalvular Atrial Fibrillation |
Q88579030 | Comparative Effectiveness of Disease Management With Information Communication Technology for Preventing Hospitalization and Readmission in Adults With Chronic Congestive Heart Failure |
Q90921530 | Comparative Therapeutic Assessment of Atrial Fibrillation in Heart Failure With Reduced Ejection Fraction-A Network Meta-Analysis |
Q47236288 | Comparative effectiveness and safety of empagliflozin on cardiovascular mortality and morbidity in adults with type 2 diabetes. |
Q47976861 | Comparison of Efficacy and Tolerance of Automatic Continuous Positive Airway Pressure Devices With the Optimum Continuous Positive Airway Pressure |
Q44229866 | Comparison of acute coronary syndromes among elderly African Americans, elderly whites, and elderly patients of other races |
Q78493667 | Comparison of acute coronary syndromes in men versus women > or = 70 years of age |
Q81405258 | Comparison of age, body mass index, and frequency of systemic hypertension and diabetes mellitus in patients having coronary angioplasty in 1996 versus in 2006 |
Q73870652 | Comparison of echocardiographic abnormalities in African-American, Hispanic, and white men and women aged >60 years |
Q80193944 | Comparison of frequency of left ventricular thrombi in patients with anterior wall versus non-anterior wall acute myocardial infarction treated with antithrombotic and antiplatelet therapy with or without coronary revascularization |
Q78245311 | Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites |
Q51337707 | Comparison of outcomes in patients with active infective endocarditis and a paravalvular abscess on a prosthetic valve versus a native valve. |
Q51656117 | Comparison of outcomes in patients with active infective endocarditis with versus without paravalvular abscess and with and without valve replacement. |
Q80803081 | Comparison of prevalence of >70% diameter narrowing of one or more major coronary arteries in patients with versus without mitral annular calcium and clinically suspected coronary artery disease |
Q83297047 | Comparison of prevalence of atherosclerotic vascular disease in postmenopausal women with osteoporosis or osteopenia versus without osteoporosis or osteopenia |
Q79207896 | Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi stress test in patients with versus without diabetes mellitus |
Q80841292 | Comparison of sensitivity, specificity, positive predictive value, and negative predictive value of stress testing versus 64-multislice coronary computed tomography angiography in predicting obstructive coronary artery disease diagnosed by coronary |
Q53642623 | Comparison of two-dimensional echocardiographic tissue harmonic imaging and gated sestamibi single-photon emission computed tomographic left ventricular ejection fraction measurements. |
Q57630103 | Complete Heart Block Complicating ST-Segment Elevation Myocardial Infarction |
Q41241862 | Complete versus culprit only revascularization in ST-elevation myocardial infarction-a perspective on recent trials and recommendations |
Q38840828 | Complex relationship of obesity and obesity paradox in heart failure - higher risk of developing heart failure and better outcomes in established heart failure |
Q46974681 | Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy |
Q41479748 | Contained Rupture of Sinus of Valsalva Aneurysm in a 64-Year-Old Man |
Q88047472 | Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines |
Q47556659 | Contemporary Sex-Based Differences by Age in Presenting Characteristics, Use of an Early Invasive Strategy, and Inhospital Mortality in Patients With Non-ST-Segment-Elevation Myocardial Infarction in the United States |
Q66699046 | Controlled trials in surgery |
Q82626434 | Coronary artery disease is more severe in older persons with rheumatoid arthritis than in older persons without rheumatoid arthritis |
Q41704062 | Correlation between electrocardiographic changes and coronary findings in patients with acute myocardial infarction and single-vessel disease |
Q69606557 | Correlation of aortic cuspal and aortic root disease with aortic systolic ejection murmurs and with mitral anular calcium in persons older than 62 years in a long-term health care facility |
Q68820162 | Correlation of atrial fibrillation with presence or absence of mitral anular calcium in 604 persons older than 60 years |
Q72382589 | Correlation of atrial fibrillation, paroxysmal supraventricular tachycardia, and sinus rhythm with incidences of new coronary events in 1,359 patients, mean age 81 years, with heart disease |
Q69740620 | Correlation of murmurs of mitral stenosis and mitral regurgitation with presence or absence of mitral anular calcium in persons older than 62 years in a long-term health care facility |
Q69172396 | Correlation of prevalence and severity of aortic regurgitation detected by pulsed Doppler echocardiography with the murmur of aortic regurgitation in elderly patients in a long-term health care facility |
Q69461261 | Correlation of prevalence and severity of mitral regurgitation and mitral stenosis determined by Doppler echocardiography with physical signs of mitral regurgitation and mitral stenosis in 100 patients aged 62 to 100 years with mitral anular calcium |
Q68826102 | Correlation of prevalence and severity of valvular aortic stenosis determined by continuous-wave Doppler echocardiography with physical signs of aortic stenosis in patients aged 62 to 100 years with aortic systolic ejection murmurs |
Q48122862 | Correlation of serum lipids with the presence or absence of atherothrombotic brain infarction and peripheral arterial disease in 1,834 men and women aged > or = 62 years |
Q72382309 | Correlation of serum lipids with the presence or absence of coronary artery disease in 1,793 men and women aged > or = 62 years |
Q69740695 | Correlation of serum lipids, calcium and phosphorus, diabetes mellitus, aortic valve stenosis and history of systemic hypertension with presence or absence of mitral anular calcium in persons older than 62 years in a long-term health care facility |
Q68979909 | Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients |
Q40190335 | Correlations of Tc-99m pyrophosphate myocardial scintigraphy and the results of coronary-artery bypass surgery |
Q44432774 | Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16]. |
Q96165143 | Corrigendum to 'Trends and Outcomes with Transcatheter versus Surgical Mitral Valve Repair in Patients >80 Years of Age' [The American Journal of Cardiology 125 (2020) 1083-1087] |
Q99718902 | Corynebacterium Jeikeium Endocarditis: A Review of the Literature |
Q45972942 | Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis. |
Q89955589 | Culprit only vs multi-vessel percutaneous coronary intervention in patients with NSTE-ACS - A meta-analysis of randomized controlled trials |
Q37982207 | Current approaches to the treatment of hypertension in older persons |
Q37047304 | Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease |
Q92580968 | Current pharmacotherapeutic strategies for cardiac arrhythmias in heart failure |
Q84564330 | Current place of beta-blockers in the treatment of hypertension |
Q37738897 | Current role of beta-blockers in the treatment of hypertension |
Q38965647 | Current treatment of heart failure with reduction of left ventricular ejection fraction |
Q38587542 | Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines |
Q43416753 | Data are needed on target blood pressure for elderly people |
Q72158281 | Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect |
Q46324361 | Demographics and payment characteristics of nursing home residents in the United States: a 23-year trend |
Q78046218 | Diabetes mellitus in older African-Americans, Hispanics, and whites in an academic hospital-based geriatrics practice |
Q35739122 | Diagnosis of heart failure in older adults: predictive value of dyspnea at rest. |
Q46331418 | Diagnosis, treatment, and referral of hypertension in an emergency department |
Q84295626 | Diagnosis, treatment, and referral of hypertension or prehypertension in an emergency department after an educational program: preliminary results |
Q50145342 | Dietary Sodium Interventions to Prevent Hospitalization and Readmission in Adults with Congestive Heart Failure |
Q46985239 | Differences in treatment and in outcomes between idiopathic and secondary forms of organizing pneumonia |
Q53588289 | Differences of lateral and septal mitral annulus velocity by tissue Doppler imaging in the evaluation of left ventricular diastolic function. |
Q40202565 | Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure |
Q52641040 | Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers. |
Q38285438 | Direct myocardial ischemia imaging: a new cardiovascular nuclear imaging paradigm. |
Q37135514 | Discharge Hospice Referral and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries Hospitalized for Heart Failure |
Q46788803 | Does beta blocker therapy affect the diagnostic accuracy of adenosine single-photon-emission computed tomographic myocardial perfusion imaging? |
Q42330841 | Does relief of outflow tract obstruction in patients with hypertrophic cardiomyopathy improve long-term survival? Implications for lowering the threshold for surgical myectomy and alcohol septal ablation |
Q44082275 | Does the serum cardiac troponin I level increase with stress test-induced myocardial ischemia? |
Q80109229 | Don't trust an LDL over 70? |
Q30471156 | Double contrast-enhanced ultrasonography evaluation of preoperative Lauren classification of advanced gastric carcinoma |
Q60922023 | Downhill esophageal varices: a therapeutic dilemma |
Q90912960 | Drug Therapy of Dyslipidemia in the Elderly |
Q82669103 | Drug therapy of older persons with hypertension |
Q52631233 | Drug treatment of hypertension in older patients with diabetes mellitus. |
Q77739145 | Drug treatment of hypertension in older persons in an academic hospital-based geriatrics practice |
Q28195312 | Drug treatment of peripheral arterial disease in the elderly |
Q36372959 | Drug treatment of systolic and of diastolic heart failure in elderly persons |
Q42359036 | Drug-induced causes of secondary hypertension |
Q43410744 | Dual stent migration to the heart and pulmonary artery |
Q51771122 | Early invasive versus initial conservative treatment strategies in octogenarians with UA/NSTEMI. |
Q38906928 | Echocardiographic evaluation of the right ventricle: Clinical implications. |
Q71551159 | Echocardiographic findings associated with atrial fibrillation in 1,699 patients aged > 60 years |
Q50513655 | Echocardiography in the Evaluation of Pulmonary Embolism. |
Q87404652 | Editorial commentary on dilemmas in treating hypertension in octogenarians |
Q41001502 | Editorial on hemoglobin A1c, blood pressure, and low-density lipoprotein cholesterol goals in diabetics |
Q35691344 | Editorial on management of diabetes mellitus with coronary artery disease |
Q70424580 | Effect of Position on the Resting and Postexercise Phonocardiogram |
Q28217674 | Effect of an ongoing educational program on the use of antiplatelet drugs, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs in patients with coronary artery disease seen in an academic cardiology clinic |
Q74666760 | Effect of benazepril on complex ventricular arrhythmias in older patients with congestive heart failure, prior myocardial infarction, and normal left ventricular ejection fraction |
Q77307418 | Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infar |
Q73935847 | Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease |
Q46524952 | Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators |
Q47889734 | Effect of carbon monoxide exposure on intermittent claudication |
Q44080458 | Effect of cardiovascular drugs on cardiovascular events in 1599 patients followed in an academic outpatient cardiology practice |
Q47369658 | Effect of carotid angioplasty-stenting on short-term mortality and stroke |
Q46863120 | Effect of carvedilol versus metoprolol CR/XL on mortality in patients with heart failure treated with cardiac resynchronization therapy: a COX multivariate regression analysis |
Q70574020 | Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction |
Q83507248 | Effect of enhanced external counterpulsation on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up |
Q42342025 | Effect of evacetrapib on cardiovascular outcomes in patients with high-risk cardiovascular disease |
Q90015831 | Effect of home-based follow-up intervention on readmissions and mortality in heart failure patients: a meta-analysis |
Q83429487 | Effect of medical therapy on left ventricular ejection fraction in patients with systolic heart failure and narrow QRS duration with and without ischemic heart disease and left ventricular mechanical dyssynchrony |
Q84670032 | Effect of mitral regurgitation on cerebrovascular accidents in patients with atrial fibrillation and left atrial thrombus |
Q72157109 | Effect of propranolol on circadian variation of myocardial ischemia in elderly patients with heart disease and complex ventricular arrhythmias |
Q71674971 | Effect of propranolol on circadian variation of ventricular arrhythmias in elderly patients with heart disease and complex ventricular arrhythmias |
Q73526425 | Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics |
Q68886960 | Effect of quinidine or procainamide versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in elderly patients with heart disease and complex ventricular arrhythmias |
Q34386295 | Effect of serum insulin on the association between hyperuricemia and incident heart failure |
Q44583593 | Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment |
Q44444796 | Effect of statins on mortality and cardiovascular events in elderly high-risk persons |
Q46688235 | Effect of statins on the development of renal dysfunction |
Q36077080 | Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillation |
Q73665631 | Effect of warfarin versus aspirin on the incidence of new thromboembolic stroke in older persons with chronic atrial fibrillation and abnormal and normal left ventricular ejection fraction |
Q36074216 | Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
Q96432177 | Effects of antidepressants on QT interval in people with mental disorders |
Q55074589 | Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders. |
Q37066497 | Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial |
Q46164268 | Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricul |
Q38924619 | Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials |
Q34019065 | Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched study |
Q38325672 | Efficacy and adverse effects of drugs used to treat adult cystic fibrosis |
Q54267504 | Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillation. |
Q80712719 | Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema |
Q91139032 | Efficacy of Sacubitril/Valsartan in Hypertension |
Q94564687 | Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients |
Q79378278 | Efficacy of radiofrequency catheter ablation in treatment of elderly patients with supraventricular tachyarrhythmias and ventricular tachycardia |
Q36205749 | Efficacy of unfractionated heparin for thromboembolism prophylaxis in medical patients |
Q39116028 | Eighth Joint National Committee guidelines |
Q44478851 | Elderly diabetics with peripheral arterial disease and no coronary artery disease have a higher incidence of new coronary events than elderly nondiabetics with peripheral arterial disease and prior myocardial infarction treated with statins and with |
Q39677658 | Elderly nursing home patients with congestive heart failure after myocardial infarction living in new york city have a higher prevalence of mortality in cold weather and warm weather months |
Q81411861 | Electrocardiographic abnormalities in patients with right ventricular dilation due to acute pulmonary embolism |
Q83248391 | Electrocardiographic abnormalities in patients with severe versus mild or moderate chronic obstructive pulmonary disease followed in an academic outpatient pulmonary clinic |
Q99729509 | Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome |
Q36455178 | Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure |
Q35183820 | Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients |
Q33161636 | Etiology of Syncope in Patients Hospitalized With Syncope and Predictors of Mortality and Readmission for Syncope at 17-Month Follow-Up: A Prospective Study |
Q33159645 | Etiology of syncope in patients hospitalized with syncope and predictors of mortality and rehospitalization for syncope at 27-month follow-up. |
Q33156366 | Etiology, pathophysiology, and treatment of atrial fibrillation: part 1. |
Q37436337 | Evaluation and management of cough. |
Q35770737 | Evaluation of left ventricular dyssynchrony using combined pulsed wave and tissue Doppler imaging |
Q100765627 | Evidence-based management of arrhythmogenic right ventricular cardiomyopathy in pregnancy |
Q84007797 | Evidence-based medicine should be practiced for primary prevention and secondary prevention of cardiovascular disease |
Q37636850 | Exercise capacity as an independent risk factor for adverse cardiovascular outcomes among nondiabetic and diabetic patients |
Q88591417 | Exercise for Preventing Hospitalization and Readmission in Adults With Congestive Heart Failure |
Q38237423 | Existing drugs and agents under investigation for pulmonary arterial hypertension |
Q100482477 | Firibastat: An Oral First-in-Class Brain Aminopeptidase A Inhibitor for Systemic Hypertension |
Q91940964 | Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies |
Q44558477 | Follow-up technetium-99m stannous pyrophosphate myocardial scintigrams after acute myocardial infarction |
Q90831441 | Frequency of 30-Day Readmission and Its Causes After Endovascular Aneurysm Intervention of Abdominal Aortic Aneurysm (from the Nationwide Readmission Database) |
Q44054651 | Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug |
Q44160620 | Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug |
Q33926447 | Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women |
Q39573955 | Giant myxoma causing heart failure symptoms |
Q104585493 | Golimumab-Associated Glomerulonephritis |
Q83181718 | Gout and hyperuricemia |
Q59683967 | HYDROPHILIC VERSUS LIPOPHILIC STATINS IN CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS |
Q38328950 | Health resource variability in the achievement of optimal performance and clinical outcome in ischemic heart disease |
Q39365014 | Heart Failure Complicating Acute Mtyocardial Infarction |
Q51816651 | Heart Failure in Older Adults. |
Q46195028 | Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction |
Q33154249 | Heart disease and aging |
Q48160359 | Heart failure biomarkers in patients with dilated cardiomyopathy |
Q80091605 | Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly |
Q46974583 | Heart failure-complicating acute myocardial infarction |
Q36663665 | Heart-failure-complicating acute myocardial infarction |
Q89687395 | Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction |
Q35827436 | Hemodynamic support with TandemHeart in tako-tsubo cardiomyopathy - a case report |
Q66958671 | Hemodynamics and Echocardiograms Before and After Cardioversion of Atrial Fibrillation to Normal Sinus Rhythm |
Q82374823 | Hemoptysis in a patient with tracheopathia osteochondroplasia |
Q37665473 | Hemoptysis: diagnosis and treatment. |
Q83181726 | Heparin-induced thrombocytopenia and thrombosis |
Q42028616 | Hereditary Amyloidosis with Recurrent Lung Infiltrates |
Q67567944 | High reversion of atrial flutter to sinus rhythm after atrial pacing in patients with pulmonary disease |
Q37407325 | Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function |
Q37248663 | Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination |
Q79099015 | Homocysteine. The association with atherosclerotic vascular disease in older persons |
Q53419913 | Hormone replacement therapy. An analysis of efficacy based on evidence. |
Q37136705 | Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure |
Q39307630 | Hydrophilic vs lipophilic statins in coronary artery disease: A meta-analysis of randomized controlled trials |
Q37854742 | Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy |
Q73852127 | Hypercholesterolemia. The evidence supports use of statins |
Q33701269 | Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes. |
Q37665486 | Hypersensitivity pneumonitis: evaluation and management |
Q92323723 | Hypertension Management in the Very Old |
Q42332220 | Hypertension and cognitive impairment |
Q42345612 | Hypertension and left ventricular hypertrophy |
Q34803207 | Hypertension and the older diabetic |
Q47135140 | Hypertension associated with atrial fibrillation |
Q84570492 | Hypertension guidelines |
Q46083134 | Hypertension highlights during 2016. |
Q38568896 | Hypertension in Sub-Saharan Africa: A Contextual View of Patterns of Disease, Best Management, and Systems Issues |
Q84960010 | Hypertension in the elderly |
Q37255548 | Hypertension in the nursing home |
Q38003574 | Hypertension therapy in the older adults-do we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly |
Q52611453 | Hypertension, aortic stenosis, and aortic regurgitation. |
Q38129267 | Hypertension-related stroke prevention in the elderly |
Q88516798 | Hypertensive disorders in pregnancy |
Q83759841 | Hyperthyroidism |
Q34019056 | Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies |
Q34560984 | Hyponatremia and cerebrovascular spasm in aneurysmal subarachnoid hemorrhage |
Q48795257 | Idiopathic Alveolar Hypoventilation Related to Head Trauma |
Q72883758 | Imaging of experimental myocardial infarction with technetium-99m 2,3-dimercaptosuccinic acid |
Q90127297 | Immune Checkpoint Inhibitors-Related Cardiotoxicity |
Q92158207 | Immunotherapy in Bladder Cancer |
Q88016820 | Impact of Cardiovascular Risk Factors on Long-Term Mortality After Liver Transplantation |
Q94661408 | Impact of Frailty on Mortality, Readmissions, and Resource Utilization After TAVI |
Q98501090 | Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date |
Q96228995 | Impact of acute kidney injury on in-hospital outcomes among patients hospitalized with acute heart failure - A propensity-score matched analysis |
Q46119873 | Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults |
Q34154209 | Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). |
Q89512841 | Impact of bedtime dosing of antihypertensives compared to morning therapy: A meta-analysis of randomised controlled trials |
Q40467123 | Impact of intraprocedural thrombotic events on short- and long-term outcomes following percutaneous coronary intervention. Evidence from a meta-analysis. |
Q50999600 | Impact of kinetic beds on the incidence of atelectasis in mechanically ventilated patients. |
Q95938307 | Impact of right ventricular impairment on morbidity and mortality in takotsubo syndrome-a meta-analysis of observational trials |
Q33747623 | Impact of sleep apnea on in-hospital outcomes after transcatheter aortic valve replacement: insight from National Inpatient Sample database 2011-2014. |
Q92964993 | Impact of weight on the efficacy and safety of direct-acting oral anticoagulants in patients with non-valvular atrial fibrillation: a meta-analysis |
Q84911850 | Implantable cardioverter-defibrillators |
Q92909608 | Implications of the New 2017 American College of Cardiology/American Heart Association Guidelines for Hypertension |
Q50118342 | Implications of the New National Guidelines for Hypertension |
Q92586201 | Improved survival and cardiovascular outcomes with renin-angiotensin inhibitor use after transcatheter aortic valve replacement |
Q37112577 | In-hospital cardiology consultation and evidence-based care for nursing home residents with heart failure |
Q79976625 | In-hospital mortality and time from onset of symptoms of acute myocardial infarction in 540 patients undergoing primary coronary angioplasty. Comparison between blacks, whites and patients of other races, and between men and women |
Q84991658 | Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator |
Q35827384 | Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up |
Q28222061 | Incidence of in-hospital mortality or nonfatal myocardial infarction or nonfatal stroke in 216 diabetics and 552 nondiabetics undergoing percutaneous coronary intervention with stenting |
Q82290911 | Incidence of myocardial infarction or stroke or death at 47-month follow-up in patients with diabetes and a predicted exercise capacity |
Q43425056 | Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol >or=125 mg/dl treated with statins versus no lipid-lowering drug |
Q36577473 | Incidence of new cardiovascular events in patients with and without peripheral arterial disease seen in a vascular surgery clinic |
Q43846801 | Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug |
Q43991551 | Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers |
Q83125026 | Incidence of new stroke or new myocardial infarction or death at 39-month follow up in patients with diabetes mellitus, hypertension, or both treated with and without angiotensin-converting enzyme inhibitors or angiotensin receptor blockers |
Q80602620 | Incidence of new stroke or new myocardial infarction or death at 39-month follow-up in patients with diabetes mellitus, hypertension or both with and without microalbuminuria |
Q79286926 | Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins |
Q84697632 | Incidence of perioperative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins |
Q35026672 | Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin. |
Q51567893 | Increased efficacy of internal carotid artery stenting using a low-profile stent with a tapered tip. |
Q51517360 | Increased fasting plasma insulin concentrations are associated with the severity of angiographic coronary artery disease. |
Q73014718 | Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons |
Q74099044 | Increased plasma homocysteine is an independent predictor of new coronary events in older persons |
Q36350108 | Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insuffic |
Q78863544 | Increased prevalence of peripheral arterial disease in older men and women with subclinical hypothyroidism |
Q46985236 | Increased vascular alpha1-adrenergic sensitivity in patients with renal failure: receiving recombinant erythropoeitin |
Q33152144 | Indications for and long-term survival in patients with automatic implantable cardioverter-defibrillators |
Q38893567 | Infections in Patients with a Total Artificial Heart are Common but Rarely Fatal |
Q33711829 | Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study |
Q52611447 | Initiation of antihypertensive therapy. |
Q91177868 | Inpatient burden of esophageal varices in the United States: analysis of trends in demographics, cost of care, and outcomes |
Q89640391 | Inpatient burden of gastric cancer in the United States |
Q81880279 | Inpatient telemetry does not need to be used in the management of older patients hospitalized with chest pain at low risk for in-hospital coronary events and mortality |
Q42535451 | Intensity of antiplatelet therapy and percutaneous coronary intervention |
Q79535750 | Intensive statin treatment or combination therapy in high-risk patients |
Q83855368 | Interhospital transfer of patients with ST-segment elevation myocardial infarction for percutaneous coronary intervention |
Q100482472 | Interventional Cardiology and Catheter-Based Interventions in Pregnancy |
Q87910839 | Interventional therapies for relief of obstruction in hypertrophic cardiomyopathy: discussion and proposed clinical algorithm |
Q36098239 | Intracoronary brachytherapy for treatment of in-stent restenosis |
Q51158249 | Intraoperative radiofrequency maze procedure for treating atrial fibrillation at the time of valve surgery or coronary artery bypass grafting. |
Q36685775 | Intravascular device infections: epidemiology, diagnosis, and management |
Q92182931 | Intravascular ultrasound-guided stent implantation reduces cardiovascular mortality - Updated meta-analysis of randomized controlled trials |
Q90724787 | Investigational drugs for the treatment of acute myocardial infarction: focus on antiplatelet and anticoagulant agents |
Q38875644 | Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study |
Q36077111 | Isolated diastolic hypotension and incident heart failure in older adults |
Q42363130 | Isolated idiopathic aortitis with an unusually thickened aortic wall: case report. |
Q90613589 | Labetalol or Amphetamine: A Case of Mistaken Identity With Clinical Consequence |
Q36860117 | Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial |
Q46132949 | Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone |
Q90301804 | Left Atrial Appendage Occlusion in the Management of Stroke in Patients With Atrial Fibrillation |
Q38731772 | Left Ventricular Assist Device in Older Adults |
Q35883269 | Left ventricular diastolic function and exercise capacity in community-dwelling adults ≥65 years of age without heart failure |
Q51384356 | Left ventricular ejection fraction and prevalence of new left ventricular wall motion abnormality at long-term follow-up in patients with automatic implantable cardioverter-defibrillators treated with dual-chamber rate-responsive pacing at a rate of |
Q71877982 | Left ventricular hypertrophy is more prevalent in patients with systemic hypertension with extracranial carotid arterial disease than in patients with systemic hypertension without extracranial carotid arterial disease |
Q51210962 | Letter by Saad et al Regarding Article, "Outcomes With Intravascular Ultrasound-Guided Stent Implantation: A Meta-Analysis of Randomized Trials in the Era of Drug-Eluting Stents". |
Q41549632 | Lifestyle measures for treating hypertension |
Q38940871 | Limitations of Sacubitril/Valsartan in the Management of Heart Failure |
Q33574532 | Lipid, blood pressure and kidney update 2013. |
Q36537938 | Lipid-lowering therapy in high-risk persons |
Q35232239 | Lipid-lowering therapy in older persons |
Q35919279 | Lipids and the elderly |
Q28259629 | Lipids, blood pressure and kidney update 2014 |
Q26771550 | Lipids, blood pressure and kidney update 2015 |
Q60684945 | Long-Term Treatment with the Apolipoprotein A1 Mimetic Peptide Increases Antioxidants and Vascular Repair in Type I Diabetic Rats |
Q38752412 | Long-term cardiovascular mortality after radiotherapy for breast cancer: A systematic review and meta-analysis |
Q36577766 | Long-term echocardiographic changes in left ventricular size and function following surgery for severe mitral regurgitation. |
Q42384664 | Losmapimod does not reduce cardiovascular events in patients with acute myocardial infarction |
Q36220674 | Lung cancer screening: history, current perspectives, and future directions |
Q37436343 | Lung cancer: the importance of early intervention. |
Q84088613 | Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction |
Q84282076 | Major adverse cardiac events at long-term follow-up in patients treated with single versus multiple stents during single-vessel percutaneous coronary intervention |
Q84428177 | Major adverse cardiac events in patients with hepatitis C infection treated with bare-metal versus drug-eluting stents |
Q43183707 | Major adverse cardiac events in patients with moderate to severe renal insufficiency treated with first-generation drug-eluting stents |
Q54002434 | Making the Case for Universal Treatment of Hypercholesterolemia. |
Q39015712 | Management and Outcomes of ST-Segment Elevation Myocardial Infarction in US Renal Transplant Recipients |
Q46394382 | Management and outcomes of ST-elevation myocardial infarction in nursing home versus community-dwelling older patients: a propensity matched study |
Q74057084 | Management of Heart Failure Attributable to Ischemic Heart Disease and Other Dilated Cardiomyopathies |
Q98505457 | Management of Thrombotic Complications in COVID-19: An Update |
Q83620357 | Management of abdominal aortic aneurysms |
Q33156993 | Management of atrial fibrillation--Part 1. |
Q37366674 | Management of atrial fibrillation--Part 2. |
Q55230811 | Management of cardiac hemochromatosis. |
Q81358360 | Management of chronic obstructive pulmonary disease |
Q37731822 | Management of hypercholesterolemia in older persons for the prevention of cardiovascular disease |
Q37362818 | Management of hyperlipidemia in older adults |
Q37018964 | Management of hyperlipidemia with statins in the older patient |
Q42344434 | Management of hypertension in patients undergoing surgery |
Q83937954 | Management of lipid disorders |
Q36524815 | Management of massive and nonmassive pulmonary embolism |
Q38042519 | Management of massive and submassive pulmonary embolism |
Q28217667 | Management of peripheral arterial disease |
Q37007841 | Management of peripheral arterial disease of the lower extremities |
Q28167570 | Management of peripheral arterial disease of the lower extremities in elderly patients |
Q41302280 | Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation |
Q28211819 | Management of the elderly person after myocardial infarction |
Q28193043 | Management of the older person with atrial fibrillation |
Q38477990 | Management of ventricular arrhythmias in structural heart disease |
Q37285996 | Management of ventricular arrhythmias. |
Q47765260 | Managing Hypertension in Patients Aged 75 Years and Older |
Q53710215 | Managing Hypertension in the Elderly: What is Different, What is the Same? |
Q36445474 | Managing hyperlipidaemia in the elderly: special considerations for a population at high risk |
Q89745739 | Managing the elderly patient with hypertension: current strategies, challenges, and considerations |
Q47136434 | Masked hypertension |
Q71845969 | Maximal treadmill stress test correlated with postexercise phonocardiogram in normal subjects |
Q42319824 | Measurement of blood pressure |
Q39311295 | Mechanical ventilation in the acute respiratory distress syndrome |
Q92426894 | Medical management after myocardial infarction |
Q38919543 | Medical therapy to prevent recurrence of ventricular arrhythmia in normal and structural heart disease patients |
Q38126374 | Medication management of chronic heart failure in older adults |
Q46624307 | Menopausal symptoms after cessation of hormone replacement therapy. |
Q89999282 | Meta-Analysis for the Use of Renin-Angiotensin Inhibitors in Post-TAVR Patients |
Q93079936 | Meta-Analysis of Direct-Acting Oral Anticoagulants Compared With Warfarin in Patients >75 Years of Age |
Q40247146 | Meta-Analysis of Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Narrowing |
Q87041816 | Meta-analysis finds benefit for dual antiplatelet therapy but limitations preclude changing standard mono antiplatelet therapy approach for acute non-cardioembolic ischaemic stroke or transient ischaemic attack |
Q94600290 | Meta-analysis of Dual Antiplatelet Therapy Versus Monotherapy With P2Y12 Inhibitors in Patients After Percutaneous Coronary Intervention |
Q87052927 | Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation |
Q61667381 | Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation |
Q35090097 | Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation |
Q44565700 | Might losartan reduce sudden cardiac death in diabetic patients with hypertension? |
Q33925600 | Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study |
Q37549369 | Milestones: a rapid assessment method for the Clinical Competency Committee |
Q38833382 | Minimizing the Risk of Bleeding with NOACs in the Elderly |
Q53389290 | Mobile physician reporting of clinically significant events-a novel way to improve handoff communication and supervision of resident on call activities. |
Q91406512 | Modifiable Risk Factors in Young Adults With First Myocardial Infarction |
Q46915816 | Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins |
Q37737944 | Mortality at long-term follow-up of patients with no, nonobstructive, and revascularized 1-, 2-, and 3-vessel obstructive coronary artery disease. |
Q73654608 | Mortality in nursing home patients with congestive heart failure |
Q80712710 | Mortality, left ventricular ejection fraction, and prevalence of new left ventricular wall motion abnormality at long-term follow-up in patients with implantable cardioverter defibrillators treated with biventricular pacing versus right ventricular |
Q36595291 | Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention |
Q87067445 | Multiple blood pressure medications and mortality among elderly individuals |
Q34836769 | Myocardial infarction in the elderly: benefits and risks of thrombolytics |
Q42318955 | Myocardial metastasis from cervical carcinoma causing left anterior descending coronary artery occlusion and ST-segment-elevation myocardial infarction |
Q52624404 | Myocarditis due to systemic lupus erythematosus associated with cardiogenic shock. |
Q91187822 | Myocarditis presenting as variant angina: a rare presentation |
Q83654723 | Nephroprotective and clinical potential of statins in dialyzed patients |
Q38910540 | Neurocardiac Injury After Cerebral and Subarachnoid Hemorrhages |
Q38326662 | Neurogenic stress cardiomyopathy associated with subarachnoid hemorrhage |
Q37861478 | Neurologic and cardiac benefits of therapeutic hypothermia. |
Q38692041 | New Invasive Assessment Measures of Coronary Artery Disease Severity |
Q35163581 | New oral anticoagulants in patients with cancer: current state of evidence |
Q37148738 | Newer anticoagulants for non-valvular atrial fibrillation |
Q60174301 | Newer hormonal pharmacotherapies for heart failure |
Q44416509 | Nicotine Gum-Induced Atrial Fibrillation |
Q35026325 | Non-ST-elevation myocardial infarction in the United States: contemporary trends in incidence, utilization of the early invasive strategy, and in-hospital outcomes |
Q38494948 | Non-typhoidal Salmonella abscess in a patient with a large thymoma: a rare presentation and review of the literature |
Q38854485 | Nonalcoholic fatty liver disease is associated with coronary artery disease and subclinical atherosclerosis |
Q87177575 | Not All NSTEMIs Are Created Equal |
Q91988190 | Novel drug therapies for cardiac amyloidosis |
Q94505970 | Novel emerging therapies in atherosclerosis targeting lipid metabolism |
Q93172370 | Obstructive bioprosthetic mitral valve thrombosis |
Q83078781 | Obstructive coronary artery disease in high-risk diabetic patients with and without atrial fibrillation |
Q37321661 | Occult left ventricular dysfunction diagnosed by myocardial performance index in patients with limb girdle muscle dystrophy: A case control study |
Q39283440 | Office management after myocardial infarction |
Q84176335 | Office management of hypertension in older persons |
Q42923969 | Office management of peripheral arterial disease |
Q46497015 | Older age should not be a barrier to the treatment of hypertension |
Q51064782 | One-year mean follow-up of 41 patients treated with bifurcation stenting. |
Q39476513 | Operationalizing the internal medicine milestones-an early status report |
Q38099479 | Optimal Blood Pressure Goals in Patients With Hypertension at High Risk for Cardiovascular Events |
Q80653558 | Optimal medical therapy after MI in the elderly |
Q52602374 | Oral Anticoagulation for Primary Prophylaxis of Venous Thromboembolism in Cancer Patients. |
Q92774734 | Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves |
Q80814219 | Oral sulfonylureas and CV mortality |
Q88086442 | Orthostatic Hypotension in Diabetics in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial |
Q33684590 | Orthostatic hypotension and incident heart failure in community-dwelling older adults |
Q35673954 | Osteoporosis, osteopenia, and atherosclerotic vascular disease |
Q35681742 | Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis |
Q83417837 | Outcomes and survival with aortic valve replacement compared with medical therapy in patients with low-, moderate-, and severe-gradient severe aortic stenosis and normal left ventricular ejection fraction |
Q33718876 | Outcomes in younger and older adults with chronic advanced systolic heart failure: A propensity-matched study |
Q92022877 | Outcomes of Thoracentesis for Acute Heart Failure in Hospitals |
Q41016689 | Outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy |
Q104283692 | Outcomes of oesophageal variceal bleeding among patients with atrial fibrillation: a propensity-matched analysis of a nationwide inpatient sample |
Q81744216 | Outpatient management of bronchial asthma in adults |
Q104283687 | Pacing at accelerated heart rate during echocardiography-guided atrioventricular optimisation following cardiac resynchronisation therapy |
Q100763410 | Paralytic ileus in the United States: A cross-sectional study from the national inpatient sample |
Q37114565 | Patient Taking A Novel Oral Anticoagulant Presents With Major GI Bleeding |
Q37321627 | Patients with echocardiographic aortic valve calcium or mitral annular calcium have an increased prevalence of moderate or severe coronary artery calcium diagnosed by cardiac computed tomography |
Q44585273 | Patients with infective endocarditis and increased cardiac troponin I levels have a higher incidence of in-hospital mortality and valve replacement than those with normal cardiac troponin I levels |
Q82676257 | Patients with ischemic stroke have a higher prevalence of a planar QRS-T angle >90° than patients with transient ischemic attack |
Q51426196 | Patients, mean age 70 years, with automatic implantable cardioverter-defibrillators treated with dual-chamber rate responsive pacing (DDDR-70) have a higher mortality than patients with backup ventricular pacing (VVI-40) at 3.7-year follow-up. |
Q38273000 | Pericardial synovial sarcoma: challenges in diagnosis and management |
Q104556582 | Perioperative Pharmacotherapy to Prevent Cardiac Complications in Patients Undergoing Noncardiac Surgery |
Q89447249 | Peripartum Cardiomyopathy Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology, and Treatment Options |
Q28217742 | Peripheral arterial disease |
Q37069056 | Peripheral arterial disease in the elderly |
Q37620677 | Peripheral arterial disease in women |
Q35990502 | Peripheral arterial disease of the lower extremities |
Q53426751 | Peripheral venoarterial extracorporeal membrane oxygenation in combination with intra-aortic balloon counterpulsation in patients with cardiovascular compromise. |
Q53465050 | Permanent pacemaker utilization in older patients with syncope and carotid sinus syndrome. |
Q47579204 | Pharmacological and non-pharmacological treatment of obstructive hypertrophic cardiomyopathy |
Q90031987 | Pharmacological management of hypertension in the elderly and frail populations |
Q38055777 | Pharmacology of antiarrhythmic drugs in elderly patients |
Q93128118 | Pharmacotherapeutics for prevention of aortic root enlargement in Marfan Syndrome - A network meta-analysis of randomized controlled trials |
Q39715667 | Physician reporting of clinically significant events through a computerized patient sign-out system. |
Q41018090 | Platelet Reactivity Unit in Predicting Risk of Bleeding in Patients Undergoing Coronary Artery Bypass Graft Surgery |
Q38809466 | Polypills for the prevention of Cardiovascular diseases |
Q30471111 | Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography |
Q53523598 | Prediction of moderate or severe pulmonary hypertension by main pulmonary artery diameter and main pulmonary artery diameter/ascending aorta diameter in pulmonary embolism. |
Q36516184 | Predictors of cardiac hepatopathy in patients with right heart failure. |
Q33636133 | Predictors of in-hospital mortality among hospitalized nursing home residents: an analysis of the National Hospital Discharge Surveys 2005-2006. |
Q33410091 | Predictors of in-hospital mortality and acute myocardial infarction in thrombotic thrombocytopenic purpura |
Q40180325 | Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus. |
Q37349595 | Predictors of mortality and hospitalization in women with heart failure in the Digitalis Investigation Group trial |
Q33162268 | Predictors of mortality, rehospitalization for syncope, and cardiac syncope in 352 consecutive elderly patients with syncope. |
Q46055663 | Pretransplant coagulopathy and in-hospital outcomes among heart transplant recipients: a propensity-matched nationwide inpatient sample study. |
Q77698504 | Prevalence and association of ventricular tachycardia and complex ventricular arrhythmias with new coronary events in older men and women with and without cardiovascular disease |
Q44533636 | Prevalence and causes of persistent use of hormone replacement therapy among postmenopausal women: a follow-up study |
Q77438197 | Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a long-term health care facility |
Q82626428 | Prevalence and prognosis of intrapulmonary shunts in patients with hepatic cirrhosis |
Q67898230 | Prevalence and severity of valvular aortic stenosis determined by Doppler echocardiography and its association with echocardiographic and electrocardiographic left ventricular hypertrophy and physical signs of aortic stenosis in elderly patients |
Q44779625 | Prevalence of Multivessel Coronary Artery Disease in Patients With Diabetes Mellitus Plus Hypothyroidism, in Patients With Diabetes Mellitus Without Hypothyroidism, and in Patients With No Diabetes Mellitus or Hypothyroidism |
Q46814240 | Prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home |
Q46903344 | Prevalence of adequate and of optimal control of serum low-density lipoprotein cholesterol in an academic nursing home |
Q80579416 | Prevalence of adequate blood pressure control in self-pay or Medicare patients versus Medicaid or private insurance patients with systemic hypertension followed in a university cardiology or general medicine clinic |
Q44079298 | Prevalence of adequate control of increased serum low-density lipoprotein cholesterol in self-pay or Medicare patients versus Medicaid or private insurance patients followed in a University General Medicine Clinic |
Q53454224 | Prevalence of an increased ascending and descending thoracic aorta diameter diagnosed by multislice cardiac computed tomography in men versus women and in persons aged 23 to 50 years, 51 to 65 years, 66 to 80 years, and 81 to 88 years. |
Q53444820 | Prevalence of an increased ascending thoracic aorta diameter diagnosed by two-dimensional echocardiography versus 64-multislice cardiac computed tomography. |
Q74443301 | Prevalence of and association between silent myocardial ischemia and new coronary events in older men and women with and without cardiovascular disease |
Q45925442 | Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators. |
Q46099927 | Prevalence of appropriate management of diabetes mellitus in an academic general medicine clinic |
Q68984566 | Prevalence of arrhythmias detected by ambulatory electrocardiographic monitoring and of abnormal left ventricular ejection fraction in persons older than 62 years in a long-term health care facility |
Q48094539 | Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. |
Q83429501 | Prevalence of complications during implantation and during 38-month follow-up of 1060 consecutive patients with implantable cardioverter-defibrillators |
Q77613872 | Prevalence of coronary artery disease, ischemic stroke, and symptomatic peripheral arterial disease and of associated risk factors in older men and women with and without diabetes mellitus |
Q80996296 | Prevalence of coronary artery disease, lower extremity peripheral arterial disease, and cerebrovascular disease in 110 men with an abdominal aortic aneurysm |
Q73081594 | Prevalence of echocardiographic findings in 554 men and in 1,243 women aged > 60 years in a long-term health care facility |
Q81230083 | Prevalence of echocardiographic left ventricular hypertrophy in persons with systemic hypertension, coronary artery disease, and peripheral arterial disease and in persons with systemic hypertension, coronary artery disease, and no peripheral arteri |
Q68979870 | Prevalence of enlarged left atrial dimension by echocardiography and its correlation with atrial fibrillation and an abnormal P terminal force in lead V1 of the electrocardiogram in 588 elderly persons |
Q83622410 | Prevalence of in-hospital complications in 500 patients undergoing percutaneous coronary intervention treated with heparin 5000 IU administered systemically versus 500 age-matched and sex-matched patients treated with heparin 70 IU/kg administered s |
Q43235237 | Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation |
Q53634547 | Prevalence of increased cardiac troponin I levels in patients with and without acute pulmonary embolism and relation of increased cardiac troponin I levels with in-hospital mortality in patients with acute pulmonary embolism. |
Q43547117 | Prevalence of influenza vaccination and pneumococcal vaccination in elderly and high-risk patients seen in a university general medicine clinic |
Q47727575 | Prevalence of left main coronary artery disease, of three- or four-vessel coronary artery disease, and of obstructive coronary artery disease in patients with and without peripheral arterial disease undergoing coronary angiography for suspected coro |
Q81838870 | Prevalence of left ventricular diastolic dysfunction in obese persons with and without diabetes mellitus |
Q48496813 | Prevalence of left ventricular hypertrophy in persons with and without obstructive sleep apnea |
Q51887012 | Prevalence of moderate and severe renal insufficiency in older persons with hypertension, diabetes mellitus, coronary artery disease, peripheral arterial disease, ischemic stroke, or congestive heart failure in an academic nursing home. |
Q82676251 | Prevalence of moderate or severe chronic kidney disease in patients with severe peripheral arterial disease versus mild or moderate peripheral arterial disease |
Q48543200 | Prevalence of moderate or severe left ventricular diastolic dysfunction in obese persons with obstructive sleep apnea |
Q81160547 | Prevalence of obstructive coronary artery disease in patients with and without prior stroke undergoing coronary angiography for suspected coronary artery disease |
Q37307543 | Prevalence of risk factors and of coronary artery disease, ischemic stroke, carotid arterial disease and lower extremity peripheral arterial disease in 96 patients undergoing elective surgery for an abdominal aortic aneurysm |
Q67746920 | Prevalence of silent myocardial ischemia detected by 24-hour ambulatory electrocardiography, and its association with new coronary events at 40-month follow-up in elderly diabetic and nondiabetic patients with coronary artery disease |
Q46541082 | Prevalence of silent myocardial ischemia in persons with diabetes mellitus or impaired glucose tolerance and association of hemoglobin A1c with prevalence of silent myocardial ischemia |
Q81622215 | Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic |
Q35755330 | Prevalence of transthoracic echocardiographic abnormalities in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage |
Q35762016 | Prevalence of use of advance directives, health care proxy, legal guardian, and living will in 512 patients hospitalized in a cardiac care unit/intensive care unit in 2 community hospitals |
Q46004873 | Prevalence of use of anticoagulants in 502 elderly hospitalized patients at increased risk for systemic embolism or venous thromboembolism without contraindications to anticoagulants in a university hospital. |
Q46763162 | Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home |
Q44390100 | Prevalence of use of cardiovascular drugs in 499 patients with suspected coronary artery disease at time of hospitalization for coronary angiography and in 357 patients with obstructive coronary artery disease documented by coronary angiography |
Q81502004 | Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure |
Q92843647 | Prevention of Recurrent Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators-A Network Meta-analysis |
Q34080023 | Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events |
Q47414871 | Prevention of venous thromboembolism in hospitalized patients. |
Q73835426 | Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction |
Q73384803 | Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm |
Q68602068 | Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease |
Q72541195 | Prognosis of congestive heart failure in patients aged > or = 62 years with unoperated severe valvular aortic stenosis |
Q70529549 | Prognostic significance of silent myocardial ischemia in patients > 61 years of age with extracranial internal or common carotid arterial disease with and without previous myocardial infarction |
Q40221373 | Prognostic value of a persistently positive technetium-99m stannous pyrophosphate myocardial scintigram after myocardial infarction |
Q84565043 | Prognostic value of cardiac troponins and natriuretic peptides in hospitalized nursing home residents |
Q38715252 | Promising new therapies for the treatment of hypercholesterolemia |
Q52840053 | Prosthetic Aortic Valve Endocarditis Without Evidence of Vegetation. |
Q47827936 | Pseudoaneurysm with thrombus and left ventricular inflow obstruction after left circumflex stenting. |
Q89593533 | Pulmonary Artery Denervation as an Innovative Treatment for Pulmonary Hypertension with and without Heart Failure |
Q33168730 | Pulmonary embolism in transit |
Q91273216 | Pulmonary hypertension in left heart disease |
Q38254244 | Pulmonary nodule: a comprehensive review and update |
Q38987225 | Pulmonary sarcoidosis: an update |
Q72857486 | Pyrophosphate myocardial imaging |
Q34986072 | Quality of care of nursing home residents hospitalized with heart failure |
Q80387620 | Race, drugs, and heart failure |
Q39077497 | Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction |
Q78844754 | Racial variations in cardiology care among hospitalized older heart failure patients |
Q100297946 | Radial vs femoral access for percutaneous coronary artery intervention in patients with ST-elevation myocardial infarction |
Q73617256 | Rate of progression of valvular aortic stenosis in patients > or = 60 years of age |
Q96772235 | Rate, Causes, and Predictors of 30-day Readmission Following Hospitalization for Acute Pericarditis |
Q97595944 | Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States |
Q37283337 | Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation |
Q58566787 | Readmissions in adult patients following hospitalization for influenza: a nationwide cohort study |
Q80172184 | Recognition and management of aortic stenosis in the elderly |
Q36092158 | Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial |
Q35843940 | Reduction in atherosclerotic events: a retrospective study in an outpatient cardiology practice |
Q47132582 | Reduction in dietary sodium improves blood pressure and reduces cardiovascular events and mortality |
Q28193061 | Reduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statins |
Q44196792 | Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins |
Q46636841 | Regional Variation in Utilization, In-hospital Mortality, and Health-Care Resource Use of Transcatheter Aortic Valve Implantation in the United States |
Q44458683 | Regional variation across the United States in management and outcomes of ST-elevation myocardial infarction: analysis of the 2003 to 2010 nationwide inpatient sample database. |
Q41189828 | Regional variation in the incidence and outcomes of in-hospital cardiac arrest in the United States |
Q39629042 | Relation of Obesity to Survival After In-Hospital Cardiac Arrest |
Q34772952 | Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure |
Q81033966 | Relation of bone mineral density to frequency of coronary heart disease |
Q84167804 | Relation of bone mineral density to stress test-induced myocardial ischemia |
Q48956007 | Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage |
Q53623763 | Relation of decreased ankle-brachial index to prevalence of atherosclerotic risk factors, coronary artery disease, aortic valve calcium, and mitral annular calcium. |
Q80308987 | Relation of increased hemoglobin A(1c) levels to severity of peripheral arterial disease in patients with diabetes mellitus |
Q51494271 | Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus. |
Q51909531 | Relation of moderate or severe reduction in glomerular filtration rate to number of coronary arteries narrowed >50% in patients undergoing coronary angiography for suspected coronary artery disease. |
Q44187971 | Relation of smoking status to outcomes after cardiopulmonary resuscitation for in-hospital cardiac arrest |
Q34020390 | Relationship between population density of attorneys and prevalence of methicillin-resistant Staphylococcus aureus: is medical-legal pressure on physicians a driving force behind the development of antibiotic resistance? |
Q47781907 | Relationship of Hospital Teaching Status with In-Hospital Outcomes for ST-Segment Elevation Myocardial Infarction |
Q37152116 | Relationship of Physical Activity and Healthy Eating with Mortality and Incident Heart Failure among Community-Dwelling Older Adults with Normal Body Mass Index |
Q38047234 | Remote patient monitoring in chronic heart failure |
Q70327329 | Remote right ventricular myocardial infarction mimicking chronic pericardial constriction |
Q39709341 | Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure |
Q36618841 | Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease |
Q46413618 | Reply: To PMID 24846806. |
Q36462951 | Resolving hyperlipidemia after liver transplantation in a patient with primary sclerosing cholangitis |
Q70541807 | Resting and Postexercise Apexcardiogram Correlated with Maximal Treadmill Stress Test in Normal Subjects |
Q71750624 | Resting and Postexercise Phonocardiogram and Electrocardiogram in Patients with Angina Pectoris and in Normal Subjects |
Q69940842 | Resting left ventricular ejection fraction in elderly patients without evidence of heart disease |
Q38970312 | Reversal agents of non-vitamin K dependent anticoagulants: a rapid review of the changing horizon |
Q35050695 | Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: a prospective cohort study |
Q37987957 | Rheumatoid arthritis: cardiovascular manifestations, pathogenesis, and therapy |
Q36806466 | Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients |
Q91245792 | Risk Factors and Outcomes During a First Acute Myocardial Infarction in Breast Cancer Survivors Compared to Females without Breast Cancer: A Nationwide Cohort Study |
Q36105688 | Risk factor reduction in progression of angiographic coronary artery disease |
Q84077217 | Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure |
Q74002599 | Risk factors for coronary artery disease in old persons in an academic hospital-based geriatrics practice |
Q70776661 | Risk factors for extracranial internal or common carotid arterial disease in elderly patients |
Q43552862 | Risk factors for hemodialysis and mortality in patients with contrast-induced nephropathy |
Q77613854 | Risk factors for ischemic stroke in older persons in an academic hospital based geriatrics practice |
Q46004833 | Risk factors for major bleeding and for minor bleeding after percutaneous coronary intervention in 634 consecutive patients with acute coronary syndromes. |
Q71181200 | Risk factors for new atherothrombotic brain infarction in 664 older men and 1,488 older women |
Q43843505 | Risk factors for new atherothrombotic brain infarction in older Hispanic men and women |
Q77442995 | Risk factors for new coronary events in older African-American men and women |
Q74791837 | Risk factors for new thromboembolic stroke in patients > or = 62 years of age with chronic atrial fibrillation |
Q73583881 | Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice |
Q69735399 | Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation |
Q33877547 | Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking |
Q57463878 | Risk prediction tools for Syncope: The quest for the holy grail |
Q89652940 | Rivaroxaban in Patients With Heart Failure and Sinus Rhythm: Meta-Analysis of Randomized Controlled Trials |
Q96582143 | Role for Risk Factor Treatment in the Management of Atrial Fibrillation |
Q83398250 | Role of Doppler echocardiography in assessing patients with acute heart failure and mitral regurgitation |
Q57068322 | Role of Geriatric Syndromes in the Management of Atrial Fibrillation in Older Adults: A Narrative Review |
Q30384180 | Role of extracorporeal membrane oxygenation in adult respiratory failure: an overview. |
Q53601156 | Role of the 12-lead electrocardiogram in diagnosing pulmonary embolism. |
Q86976406 | ST elevation myocardial infarction after tranexamic acid: first reported case in the United States |
Q34356345 | ST-elevation myocardial infarction in the elderly--temporal trends in incidence, utilization of percutaneous coronary intervention and outcomes in the United States |
Q64327462 | Sacubitril/valsartan in cardiovascular disease: evidence to date and place in therapy |
Q36803115 | Secondary hypertension: current diagnosis and treatment |
Q72843027 | Sensitivity and Specificity of Tc-99m-Pyrophosphate Myocardial Scintigraphy for the Detection of Acute Myocardial Infarction |
Q45108372 | Sensitivity, specificity, positive predictive value, and negative predictive value of the dipyridamole sestamibi stress test comparing arterial to vein conduits |
Q45040775 | Sensitivity, specificity, positive predictive value, and negative predictive value of the dipyridamole sestamibi stress test in predicting graft occlusion or > or = 50% new native coronary artery disease in men versus women and in patients aged > or |
Q91975901 | Seronegative atypical anti-glomerular basement membrane crescentic glomerulonephritis |
Q92212434 | Serum Bilirubin and Coronary Artery Disease: Intricate Relationship, Pathophysiology, and Recent Evidence |
Q37255465 | Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction |
Q73114410 | Serum ferritin is not a risk factor for extracranial carotid arterial disease in men and women aged > or = 60 years |
Q92201900 | Severe Hypoglycemia and Risk of Subsequent Cardiovascular Events: Systematic Review and Meta-Analysis of Randomized Controlled Trials |
Q92860695 | Severely blunted early heart rate response during treadmill exercise is associated with above average exercise capacity |
Q100514892 | Sex Differences in In-Hospital Outcomes of Transcatheter Aortic Valve Replacement |
Q102327137 | Sex differences in cardiovascular diseases and associated risk factors in non-alcoholic steatohepatitis |
Q98458109 | Should elevated blood pressure be treated with antihypertensive drug therapy? |
Q73527969 | Should hypercholesterolemia be treated in frail elders? |
Q44041944 | Should hypercholesterolemia in older persons be treated to reduce cardiovascular events? |
Q46561822 | Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events? |
Q44888517 | Should the National Cholesterol Education Program guidelines be changed for persons at high risk for cardiovascular events? |
Q27002407 | Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly |
Q72005543 | Signal-averaged electrocardiography and ventricular tachycardia as predictors of mortality after acute myocardial infarction in elderly patients |
Q71621348 | Signal-averaged electrocardiography in elderly subjects with and without heart disease |
Q78837781 | Silent MI. Prevalence and prognosis in older patients diagnosed by routine electrocardiograms |
Q46132135 | Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial. |
Q80464957 | Simultaneous measurements of blood pressures in right and left brachial arteries |
Q36831928 | Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention |
Q79780783 | Spinal Cord Stimulation for the Treatment of Angina Pectoris |
Q34216532 | Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.). |
Q91078553 | Sputum culture for the diagnosis of tuberculous pleural effusion: analysis of absolute and incremental yields |
Q66912482 | Standards for Surgical Trials |
Q91395943 | Starvation Ketoacidosis due to the Ketogenic Diet and Prolonged Fasting - A Possibly Dangerous Diet Trend |
Q104569668 | State-Level Temporal Trends in Smokeless Tobacco and Cigarette Use Among U.S. Adults |
Q35232279 | Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel |
Q59684216 | Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel |
Q37393348 | Statin therapy in the elderly: a review |
Q99569977 | Statins and Higher Diabetes Mellitus Risk: Incidence, Proposed Mechanisms and Clinical Implications |
Q33787152 | Statins and dilated cardiomyopathy: do we have enough data? |
Q93042045 | Statins and the potential for higher diabetes mellitus risk |
Q43875066 | Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy |
Q84644316 | Statins reduce cardiovascular events in primary and secondary prevention trials without causing an increase in carcinoma |
Q91858481 | Stress (Takotsubo) Cardiomyopathy; A Review of its Pathophysiology, Manifestations, and Factors that Affect Prognosis |
Q44145613 | Subclinical hypothyroidism is associated with coronary artery disease in older persons |
Q38448829 | Sudden Cardiac Arrest in a Patient With Apical Hypertrophic Cardiomyopathy: Case Report and a Brief Review of Literature. |
Q90127345 | Sudden Cardiac Death in Brugada Syndrome |
Q100456524 | Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era |
Q33161733 | Syncope: Approaches to Diagnosis and Management |
Q100429954 | Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension |
Q49951618 | Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction |
Q92912723 | Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction |
Q42109672 | Systolic compression of left main coronary artery by left ventricular pseudoaneurysm complicated by critical stenosis of left main coronary artery |
Q38909059 | Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study. |
Q42565401 | T cell lymphoma presenting as esophageal obstruction and bronchoesophageal fistula. |
Q100456521 | Takotsubo Cardiomyopathy Secondary to Rituximab |
Q42709028 | Takotsubo syndrome (or apical ballooning syndrome) secondary to Zolmitriptan |
Q71151635 | Technetium-99m stannous pyrophosphate myocardial scintigrams in pericardial disease |
Q99709968 | Temporal Trends and Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Renal Transplants |
Q40376957 | Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States |
Q47107131 | Temporal trends and outcomes of acute myocardial infarction in patients with cancer. |
Q35022026 | Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study |
Q84570824 | Ten key points from the American College of Cardiology Foundation/American Heart Association 2011 expert consensus document on hypertension in the elderly |
Q37944849 | Ten most important things to learn from the ACCF/AHA 2011 expert consensus document on hypertension in the elderly |
Q102326662 | Testicular adrenal rest tumors diagnosed on ultrasound with a history of congenital adrenal hyperplasia and medication non-compliance |
Q37366680 | Testing for tuberculosis infection |
Q34746089 | The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe |
Q39399845 | The Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Postangioplasty Restenosis |
Q39365021 | The Role of Positive Inotropic Drugs in the Treatment of Older Adults with Heart Failure and Reduced Ejection Fraction |
Q36407046 | The application of evidence-based principles of care in older persons (issue 2): management of lipid disorders |
Q50999596 | The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents versus bare-metal stents during percutaneous coronary intervention. |
Q92842827 | The correlation between sarcopaenia and post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy: a single-institution review |
Q79774886 | The effects of off-normal hours, age, and gender for coronary angioplasty on hospital mortality in patients undergoing coronary angioplasty for acute myocardial infarction |
Q41549636 | The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan |
Q43633554 | The high-risk angina patient. Identification by clinical features, hospital course, electrocardiography and technetium-99m stannous pyrophosphate scintigraphy |
Q35843935 | The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice |
Q82746173 | The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice |
Q91034315 | The left ventricular ejection fraction: new insights into an old parameter |
Q37903098 | The meaning of hypokalemia in heart failure |
Q35626691 | The prevention of venous thromboembolism in older adults: guidelines |
Q90442974 | The relationship between atypical antipsychotics drugs and cardiac arrhythmias: implications for clinical use |
Q67773815 | The vectorcardiogram in the diagnosis of inferior wall myocardial infarction |
Q37885133 | Therapeutic options for obstructive sleep apnea |
Q36286252 | Therapeutic options for severe asthma |
Q83620369 | Therapy of patients hospitalized for heart failure with abnormal versus normal left ventricular ejection fraction |
Q39051923 | Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database |
Q35674015 | Thoracic aortic atheroma severity predicts high-risk coronary anatomy in patients undergoing transesophageal echocardiography |
Q71590710 | Three-year follow-up shows no association of serum ferritin levels with incidence of new coronary events in 577 persons aged > or = 62 years |
Q43231648 | Thromboembolism in patients with atrial fibrillation with and without left atrial thrombus documented by transesophageal echocardiography |
Q35580941 | Thrombolytic therapy is indicated for patients over 75 years of age with st-elevation acute myocardial infarction: antagonist viewpoint |
Q100456513 | Tocilizumab-Associated Bowel Perforation in SARS-CoV-2 Infection |
Q83065656 | Topics in clinical pharmacology: cardiovascular and diabetes mellitus |
Q90818919 | Tracheobronchitis with stridor in a patient with ulcerative colitis |
Q91117984 | Transcatheter Versus Surgical Aortic Valve Replacement in Rheumatic Aortic Valve Disease-A Nationwide Analysis |
Q104463606 | Transcatheter closure for the treatment of pseudoventricular aneurysm after acute myocardial infarction: a case report |
Q38279691 | Treating hypertension and prehypertension in older people: when, whom and how. |
Q33157131 | Treating hypertension in older adults: safety considerations |
Q36993983 | Treatment after myocardial infarction |
Q39364999 | Treatment of Heart Failure with Abnormal Left Ventricular Systolic Function in Older Adults |
Q38595892 | Treatment of Hypercholesterolemia in 2015. |
Q57565105 | Treatment of Hypertension in Patients With Coronary Artery Disease |
Q74057771 | Treatment of Hypertension in the Institutionalized Elderly |
Q92513083 | Treatment of Mild Aortic Stenosis With Statins |
Q74057573 | Treatment of Older Patients With CHF Associated With Normal LVEF |
Q89695324 | Treatment of Peripheral Pulmonary Artery Stenosis |
Q33699764 | Treatment of Stable Angina Pectoris |
Q39365044 | Treatment of Ventricular Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Older Adult Patients with Cardiac Disease |
Q51437775 | Treatment of abdominal aortic aneurysms with an endovascular stent-graft prosthesis in 96 high-risk patients. |
Q37245746 | Treatment of atrial fibrillation and atrial flutter: Part II. |
Q28196537 | Treatment of heart failure in older persons. Dilemmas with coexisting conditions: diabetes mellitus, chronic obstructive pulmonary disease, and arthritis |
Q36663657 | Treatment of heart failure with abnormal left ventricular systolic function in the elderly |
Q46974586 | Treatment of heart failure with abnormal left ventricular systolic function in the elderly |
Q36953006 | Treatment of heart failure with decreased left ventricular ejection fraction |
Q37007825 | Treatment of heart failure with normal left ventricular ejection fraction |
Q37115317 | Treatment of high-risk older persons with lipid-lowering drug therapy |
Q35647419 | Treatment of hypertension and prevention of ischemic stroke |
Q57565098 | Treatment of hypertension in patients with coronary artery disease |
Q28080534 | Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension |
Q34469638 | Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. |
Q82171684 | Treatment of hypertension in the elderly |
Q83176012 | Treatment of hypertension in the elderly |
Q87317285 | Treatment of hypertension in the elderly |
Q42347996 | Treatment of hypertensive emergencies |
Q38292224 | Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance |
Q43204253 | Treatment of patients with supraventricular tachyarrhythmias in a medical intensive care unit. |
Q79836615 | Treatment of postmenopausal osteoporosis |
Q36577681 | Treatment of pulmonary hypertension |
Q92125296 | Treatment of resistant hypertension |
Q36190285 | Treatment of systemic hypertension. |
Q36368542 | Treatment of systolic and diastolic heart failure in the elderly |
Q46200204 | Treatment of systolic hypertension and low diastolic blood pressure in older adults: How low is too low?! |
Q52611415 | Treatment of thoracic aortic aneurysm. |
Q28165775 | Treatment of unstable angina pectoris/non-ST-segment elevation myocardial infarction in elderly patients |
Q37454224 | Treatment of ventricular arrhythmias in the elderly |
Q92941036 | Trends and Outcomes With Transcatheter Versus Surgical Mitral Valve Repair in Patients ≥80 Years of Age |
Q97562139 | Trends and outcomes of Peptic Ulcer Disease in patients with Cirrhosis |
Q40351202 | Trends in Coronary Angiography, Revascularization, and Outcomes of Cardiogenic Shock Complicating Non-ST-Elevation Myocardial Infarction |
Q45733923 | Trends in acute kidney injury and outcomes after early percutaneous coronary intervention in patients ≥75 years of age with acute myocardial infarction |
Q37648570 | Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States |
Q41337798 | Trends in management and outcomes of ST-elevation myocardial infarction in patients with end-stage renal disease in the United States |
Q90129288 | Trends of Cardiac Complications in Patients With Rheumatoid Arthritis: Analysis of the United States National Inpatient Sample; 2005-2014 |
Q39003460 | Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis |
Q36737062 | Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease |
Q48174037 | Type B Lactic Acidosis Associated With Venlafaxine Overdose |
Q38258030 | Umeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical use. |
Q34038855 | Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study |
Q35167371 | Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents |
Q28193045 | Underutilization of aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home |
Q36071081 | Underutilization of calcium and vitamin D by older adults in a large general internal medicine practice |
Q38711646 | Uninterrupted New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Ablation of Atrial Fibrillation: A Meta-analysis |
Q60922017 | Unstable angina: trends and characteristics associated with length of hospitalization in the face of diminishing frequency-an evidence of a paradigm shift |
Q88979543 | Update of treatment of heart failure with reduction of left ventricular ejection fraction |
Q37993133 | Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults |
Q38157555 | Update on pharmacologic therapy for pulmonary embolism |
Q38846020 | Update on pulmonary arterial hypertension pharmacotherapy |
Q46472561 | Updated National Cholesterol Education Program III guidelines |
Q37359892 | Updates on cytochrome P450-mediated cardiovascular drug interactions |
Q37699864 | Updates on cytochrome p450-mediated cardiovascular drug interactions |
Q26774435 | Use of Inotropic Agents in Treatment of Systolic Heart Failure |
Q41453451 | Use of MKSAP 16 for American Board of Internal Medicine Examination |
Q89178923 | Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender |
Q35154763 | Use of antihypertensive drug therapy in older persons in an academic nursing home |
Q94195236 | Use of antihypertensive drug therapy in older persons in an academic nursing home |
Q28211355 | Use of antiplatelet drugs in secondary prevention in older persons with atherothrombotic disease |
Q28222320 | Use of antiplatelet drugs in secondary prevention in patients with atherothrombotic disease |
Q38122212 | Use of antiplatelet drugs in the treatment of acute coronary syndromes |
Q38040468 | Use of antiplatelet therapy after percutaneous coronary intervention with bare-metal stents and different types of drug-eluting stents |
Q37556490 | Use of endoscopic ultrasound. |
Q37665469 | Use of enhanced counterpulsation in the treatment of refractory angina pectoris and congestive heart failure |
Q36149372 | Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial |
Q37818218 | Use of implantable cardioverter-defibrillators |
Q92236838 | Use of levosimendan in acute and advanced heart failure: short review on available real-world data |
Q87927777 | Use of ranolazine in patients with stable angina pectoris |
Q81743295 | Use of reperfusion therapy and cardiovascular drugs in the treatment of 146 men and 54 women with ST-segment elevation myocardial infarction at a University Medical Center |
Q72306468 | Usefulness of an abnormal signal-averaged electrocardiogram for predicting cardiac death in elderly persons without heart disease |
Q68385752 | Usefulness of echocardiographic abnormal left ventricular ejection fraction, paroxysmal ventricular tachycardia and complex ventricular arrhythmias in predicting new coronary events in patients over 62 years of age |
Q68734760 | Usefulness of echocardiographic left ventricular ejection fraction and silent myocardial ischemia in predicting new coronary events in elderly patients with coronary artery disease or systemic hypertension |
Q41197268 | Usefulness of echocardiographic left ventricular hypertrophy and silent ischemia in predicting new cardiac events in elderly patients with systemic hypertension or coronary artery disease |
Q70053018 | Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atherothrombotic brain infarction in patients over 62 years of age |
Q70064269 | Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients |
Q68713279 | Usefulness of silent ischemia, ventricular tachycardia, and complex ventricular arrhythmias in predicting new coronary events in elderly patients with coronary artery disease or systemic hypertension |
Q67975582 | Usefulness of silent myocardial ischemia detected by ambulatory electrocardiographic monitoring in predicting new coronary events in elderly patients |
Q73349999 | Utilization of lipid-lowering drugs in elderly persons with increased serum low-density lipoprotein cholesterol associated with coronary artery disease, symptomatic peripheral arterial disease, prior stroke, or diabetes mellitus before and after an |
Q67443955 | Value of the Vectorcardiogram in Assessing Tall R Waves in Right Precordial Leads |
Q90085923 | Valve-in-Valve Transcatheter Implantation Versus Redo Surgical Aortic Valve Replacement |
Q99636077 | Valvular Heart Disease in Pregnancy: Anticoagulation and the Role of Percutaneous Treatment |
Q28219506 | Valvular aortic stenosis in the elderly |
Q56532573 | Variant Angina and Aborted Sudden Cardiac Death |
Q46307137 | Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device |
Q64892552 | Vulnerable Plaque: A Review of Current Concepts in Pathophysiology and Imaging. |
Q34648874 | Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves |
Q53150908 | Warfarin use and prevalence of coronary artery calcification assessed by multislice computed tomography. |
Q28194645 | Warfarin, aspirin, or both after myocardial infarction |
Q96167632 | Wellens' syndrome: a rare presentation after an endoscopic retrograde cholangiopancreatography |
Q89269098 | What Should the Optimal Systolic Blood Pressure Goal Be in Treating Older Persons with Hypertension? |
Q74530499 | What is the appropriate treatment of hypertension in elders? |
Q38676286 | What should the blood pressure be in patients with a prior ischemic stroke or a transient ischemic attack? |
Q42319822 | What should the blood pressure be in patients with chronic kidney disease? |
Q85855505 | What should the blood pressure goal be in patients with hypertension who are at high risk for cardiovascular disease? |
Q42332669 | What should the blood pressure treatment goal be in adults with hypertension in 2016? |
Q36105676 | What should the optimal blood pressure goal be in patients with diabetes mellitus or chronic kidney disease? |
Q37412697 | What should the target blood pressure goals be? |
Q84564344 | Why and how we should treat elderly patients with hypertension? |
Q28166204 | Effect of an educational program on the prevalence of use of antiplatelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge |
Search more.